Banyan Biotech - Innovating Regenerative Medicine

Founder

Banyan Biotech, based in Milan, pioneers advanced therapies in regenerative medicine to transform patient care.Our commitment to innovation drives us to develop solutions that restore health and improve lives. Join us on a journey to revolutionize healing through biotechnology.

Novel Coronavirus SARS-CoV-2 (Omicron) Colorized scanning electron micrograph of a cell (teal) infected with the Omicron strain of SARS-CoV-2 virus particles (purple), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID https://www.flickr.com/photos/niaid/53428060507/

Innovating Regenerative Medicine

DNA Genotyping and Sequencing. Technician prepares for a viral whole-genome sequencing experiment at the Cancer Genomics Research Laboratory, part of the National Cancer Institute's Division of Cancer Epidemiology and Genetics (DCEG).

Gallery

Regenerating life, inspiring futures with innovation.

Discover the power of biotechnology!

Reach Out to Us

Lucia Zaccardi, CEO and Founder of Banyan Biotech, is a Senior R&amp;D Pharmaceutical Researcher with over 25 years of experience driving innovation in regenerative medicine and longevity science.She leads the integration of advanced scientific and digital approaches, including AI, Modeling &amp; Simulation, in silico methodologies, Digital Medicine, Digital Therapeutics (DTx), and Real-World Evidence (RWE), to accelerate therapeutic development and improve prediction, personalization, and clinical outcomes.A strong advocate of space and microgravity research, Lucia collaborates with biotech, aerospace, and academic partners to pioneer next-generation pharmaceutical innovation at the intersection of biology, technology, and space.

Lucia Zaccardi

Founder and CEO

Alessia Forzina is the Founder and Chief Scientific Officer, with a background in pharmacology and hands-on experience across the drug development lifecycle, from drug discovery and preclinical data generation through to clinical development.She works at the intersection of science and strategy, contributing to clinical protocol design and development strategies, and collaborating with cross-functional and international teams to translate complex data into clear, actionable input for decision making.With a pragmatic, evidence-based approach, Alessia supports global initiatives by aligning scientific innovation with development and business needs, focusing on execution, long-term value creation, and meaningful impact for patients.